Results 131 to 140 of about 1,027,648 (153)
Some of the next articles are maybe not open access.
Venoactive drugs for venous origin chronic pelvic pain in women: A systematic review
PhlebologyBackground This review evaluates the current evidence for the role of venoactive drugs (VADs) for venous origin chronic pelvic pain (VO-CPP) and provide insights to inform the design of an ideal randomized controlled trial (RCT) for future research ...
Neil M Khilnani +2 more
exaly +3 more sources
Vascular Medicine
Background: The efficacy of venoactive drug (VAD) treatment for pelvic venous disorder (PeVD) has not been fully investigated. This study was aimed at evaluating the efficacy and safety of different diosmin-containing agents in women with PeVD.
Sergey G Gavrilov +2 more
exaly +3 more sources
Background: The efficacy of venoactive drug (VAD) treatment for pelvic venous disorder (PeVD) has not been fully investigated. This study was aimed at evaluating the efficacy and safety of different diosmin-containing agents in women with PeVD.
Sergey G Gavrilov +2 more
exaly +3 more sources
Flebologiya
Onset and duration of effect of venoactive drug (VAD) and topical agent on venous symptoms are unclear. Objective — to determine onset and duration of the effect of treatment with VAD and/or local gel use on venous symptoms. Material and methods. 121 patients (C1—C3S) were included in the multicenter prospective study. First group patients received VAD
Suchkov I A, I A Suchkov, A A Kamaev
exaly +2 more sources
Onset and duration of effect of venoactive drug (VAD) and topical agent on venous symptoms are unclear. Objective — to determine onset and duration of the effect of treatment with VAD and/or local gel use on venous symptoms. Material and methods. 121 patients (C1—C3S) were included in the multicenter prospective study. First group patients received VAD
Suchkov I A, I A Suchkov, A A Kamaev
exaly +2 more sources
Annals of Vascular Surgery
To study and compare the effects of venoactive drug (VAD) therapy and ovarian vein embolization or resection (OVE or OVR, accordingly) on the levels of vasoactive peptides and cytokines in patients with pelvic venous disorders (PeVDs).The study included 70 consecutive female patients with PeVD symptoms, such as chronic pelvic pain (CPP), dyspareunia ...
Sergey G Gavrilov +2 more
exaly +3 more sources
To study and compare the effects of venoactive drug (VAD) therapy and ovarian vein embolization or resection (OVE or OVR, accordingly) on the levels of vasoactive peptides and cytokines in patients with pelvic venous disorders (PeVDs).The study included 70 consecutive female patients with PeVD symptoms, such as chronic pelvic pain (CPP), dyspareunia ...
Sergey G Gavrilov +2 more
exaly +3 more sources
Use of venoactive drugs after surgery for varicose veins: a preliminary study
International Angiology, 2018The aim of this paper was to assess the use of venoactive drugs (VADs) after surgery for chronic venous disease in our operative unit in terms of patients' compliance to the therapy and a possible effect on the postoperative pain and quality of life (QoL).Data of consecutive patients who underwent surgery were retrospectively analyzed.
Daniela, Mazzaccaro +5 more
openaire +2 more sources
International Angiology, 2023
Vein-specific inflammation leads to vascular smooth muscle cells proliferation and extracellular matrix degradation of vein wall. This process is known as remodeling and is promoted by "trapped" leukocytes. Monocyte chemoattractant protein 1 (MCP-1) is a chemokine responsible for trafficking of leukocytes from blood to vein wall.
Igor, Zolotukhin +4 more
openaire +2 more sources
Vein-specific inflammation leads to vascular smooth muscle cells proliferation and extracellular matrix degradation of vein wall. This process is known as remodeling and is promoted by "trapped" leukocytes. Monocyte chemoattractant protein 1 (MCP-1) is a chemokine responsible for trafficking of leukocytes from blood to vein wall.
Igor, Zolotukhin +4 more
openaire +2 more sources
Clinical evidence of venoactive drugs in diabetic microvascular complications: a scoping review
International AngiologyDiabetic microvascular complications (DmVCs) and chronic venous disease (CVD) share common risk factors and pathophysiological features. However, they are often assessed and managed as separate conditions. The study objective was to map the available clinical evidence of venoactive drugs (VADs), beyond their demonstrated effects on sign and symptoms of
Giacomo, Gastaldi +9 more
openaire +5 more sources
, 2011 Vnitřní lékařství, 2022
The article provides an overview of the development of recommendations for indications of venoactive drugs for treating symptoms and signs associated with chronic venous disease (CVD). Venoactive drugs may be beneficial in patients with subjective problems and/or swelling of the lower limbs, after surgery for varicose veins, in chronic venous ...
openaire +2 more sources
The article provides an overview of the development of recommendations for indications of venoactive drugs for treating symptoms and signs associated with chronic venous disease (CVD). Venoactive drugs may be beneficial in patients with subjective problems and/or swelling of the lower limbs, after surgery for varicose veins, in chronic venous ...
openaire +2 more sources